Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 14, 2019

Comparative expression analysis of phospholipid binding protein annexina1 in nephrogenesis and kidney cancer

  • Roshni Sadashiv , Balappa Murgappa Bannur , Praveenkumar Shetty EMAIL logo , Udupi Shastry Dinesh , Jamboor K.Vishwanatha , Subhash Krishnarao Deshpande , Anil Bargale , Sarathkumar E and Komal Ruikar

Abstract

Background

The expression in the glomerular mesangial cells, papillary, and collecting duct cells demonstrated annexin A1 (AnxA1)’s role in specific renal functions. With varying concentrations of calcium (Ca2+), it is considered to regulate cellular processes such as cell proliferation, apoptosis, and clearance of apoptotic cells by forming ceramides, a key lipid mediator of apoptosis. It also participates in tumorigenesis based on its location. On account of these features, we investigated the expression of this apoptosis-associated protein in fetal kidneys at different gestational periods, mature kidneys and in kidney cancer tissues in order to localize and possibly characterize its role during nephrogenesis and renal tumors.

Methods

AnxA1 expression was evaluated by an immunohistochemistry technique in paraffin-embedded” renal tissue sections from autopsied fetuses at different gestational ages, in mature kidneys and renal cancer tissues.

Results

The current study data demonstrated that AnxA1 is expressed in the mesangial cells and podocytes of maturing glomeruli in the developing renal cortex of fetal kidneys at 14 to 19 weeks of gestation. The expression in the mesangial cells declined in later weeks of gestation and persisted into adulthood. AnxA1 expression increased with the progression of clear cell renal cell carcinoma (CCRCC) and also in other cancer types indicating a potential role of the protein in tumorigenesis.

Conclusions

We presume that AnxA1 in the podocytes and mesangial cells play important roles in various signaling pathways in the functioning of the glomerulus. These results and concepts provide a framework to further dissect its biological properties and thereby develop diagnostic, prognostic, and therapeutic strategies targeting the molecule in various renal pathologies.

Acknowledgments

The authors would like to acknowledge the help of Mr. Clinton D’ Souza and Mr. ShashidharAngadi for technical assistance.

  1. Author contributions: Conceived the idea and designed the experiments: RS and PKS; helped in clinical sample collection and correlated the clinical relevance to the study: USD, BMB and SKD; Performed the experiments: RS, SE, AB, and KR; analyzed the data (pathology): USD. Analyzed the data (statistical analysis): RS, PKS, JKV, and AB; manuscript preparation: RS and PKS; revised the manuscript: PKS and JKV; supervised the overall study: PKS and BMB.

  2. Research funding: None declared.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects compliedwith all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors’ Institutional Review Board or equivalent committee.

References

[1] Moore KL, Persaud TV, editors. The developing human: clinically oriented embryology, 8th ed. Philadelphia, PA: Saunders, 2008:244–60.Search in Google Scholar

[2] Lacson A, Bernstein J, Risdon RA, Gilbert-Barness E. Renal system. In: Gilbert-Barness E, editor. Potter’s pathology of the fetus, infant and child. 2nd ed. Philadelphia, PA: Elsevier Mosby, 2007:1281–344.Search in Google Scholar

[3] Alexander DP, Nixon DA. The foetal kidney. Br Med Bull 1961;17:112–7.10.1093/oxfordjournals.bmb.a069883Search in Google Scholar

[4] Jeon YJ, Kim J, Chae JI. Comparative proteomic analysis of kidney development-related proteins in the pig. Vitr Cell Dev Biol Anim 2013;49:315–23.10.1007/s11626-013-9602-8Search in Google Scholar

[5] Leroy X, Devisme L, Buisine MP, Copin MC, Aubert S, Gosselin B, et al. Expression of human mucin genes during normal and abnormal renal development. Am J Clin Pathol 2003;120:544–50.10.1309/A9YM1CBQDYFRC2EYSearch in Google Scholar

[6] Dormoy V, Jacqmin D, Lang H, Massfelder T. From development to cancer: lessons from the kidney to uncover new therapeutic targets. Anticancer Res 2012;32:3609–17.Search in Google Scholar

[7] Tong GX, Yu WM, Beaubier NT, Weeden EM, Hamele-Bena D, Mansukhani MM, et al. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol 2009;22:1218–27.10.1038/modpathol.2009.88Search in Google Scholar

[8] Monastyrskaya K, Babiychuk EB, Draeger A. The annexins: spatial and temporal coordination of signaling events during cellular stress. Cell Mol Life Sci 2009;66:2623–42.10.1007/s00018-009-0027-1Search in Google Scholar

[9] Kang WY, Chen WT, Huang YC, Su YC, Chai CY. Overexpression of annexin 1 in the development and differentiation of urothelial carcinoma. Kaohsiung J Med Sci 2012;28:145–50.10.1016/j.kjms.2011.10.004Search in Google Scholar

[10] Markoff A, Gerke V. Expression and functions of annexins in the kidney. Am J Physiol Renal Physiol 2005;289:F949–56.10.1152/ajprenal.00089.2005Search in Google Scholar

[11] Biaoxue R, Xiguang C, Shuanying Y. Annexin A1 in malignant tumors: current opinions and controversies. Int J Biol Markers 2014;29:e8–20.10.5301/jbm.5000046Search in Google Scholar

[12] Pin AL, Houle F, Fournier P, Guillonneau M, Paquet ÉR, Simard MJ, et al. Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by vascular endothelial growth factor (VEGF)-induced inhibition of miR-196a expression. J Biol Chem 2012;287:30541–51.10.1074/jbc.M112.393561Search in Google Scholar

[13] Arur S, Uche UE, Rezaul K, Fong M, Scranton V, Cowan AE, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 2003;4:587–98.10.1016/S1534-5807(03)00090-XSearch in Google Scholar

[14] Belvedere R, Bizzarro V, Popolo A, Dal Piaz F, Vasaturo M, Picardi P, et al. Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells. BMC Cancer 2014;14:1–15.10.1186/1471-2407-14-961Search in Google Scholar PubMed PubMed Central

[15] Tribolo S, Maroux S, Massey-Harroche D. Kidney proximal tubule cells: epithelial cells without EGTA-extractable annexins? Biochem Cell Biol 2000;78:495–502.10.1139/o00-061Search in Google Scholar

[16] Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends Cell Biol 2013;23:620–33.10.1016/j.tcb.2013.07.006Search in Google Scholar PubMed PubMed Central

[17] Woolf AS, Jenkins D. Development of the kidney. In: Jennette JC, Olson JL, Silva FG, D’Agati VD, editors. Heptinstall’s pathology of the kidney, 7th ed. Philadelphia, PA: Wolters Kluwer Health, 2015:67–89.Search in Google Scholar

[18] Chikkannaiah P, Roy M, Kangle R, Patil PV. Glomerulogenesis: can it predict the gestational age? a study of 176 fetuses. Indian J Pathol Microbiol 2012;55:303–7.10.4103/0377-4929.101734Search in Google Scholar PubMed

[19] Eble NJ, Grignon JD, Young HR. Tumors of the urinary tract. In: Fletcher MDC, editor. Diagnostic histopathology of tumors, 4th ed. Philadelphia, PA: Elsevier Saunders, 2013:559–601.Search in Google Scholar

[20] Cheng CW, Rifai A, Ka SM, Shui HA, Lin YF, Lee WH, et al. Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int 2005;68:2694–703.10.1111/j.1523-1755.2005.00740.xSearch in Google Scholar PubMed

[21] Hudkins KL, Giachelli CM, Cui Y, Couser WG, Johnson RJ, Alpers CE. Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 1999;10:444–57.10.1681/ASN.V103444Search in Google Scholar PubMed

[22] Lacunza E, Ferretti V, Barbeito C, Segal-Eiras A, Croce MV. Immunohistochemical evidence of Muc1 expression during rat embryonic development. Eur J Histochem 2010;54:e49.10.4081/ejh.2010.e49Search in Google Scholar PubMed PubMed Central

[23] Tank KC, Saiyad SS, Pandya AM, Akbari VJ, Dangar KP. A study of histogenesis of human fetal kidney. Int J Biol Med Res 2012;3:1315–21.Search in Google Scholar

[24] Bertelli E, Regoli M, Fonzi L, Occhini R, Mannucci S, Ermini L, et al. Nestin expression in adult and developing human kidney. J Histochem Cytochem 2007;55:411–21.10.1369/jhc.6A7058.2007Search in Google Scholar PubMed

[25] Bonsib FM. Renal anatomy and histology. In: Jennette JC, editor. Heptinstall’s pathology of the kidney, 7th ed. Philadelphia, PA: Wolters Kluwer Health, 2015:1–65.Search in Google Scholar

[26] Young B, Lowe JS, Stevens A, Heath JW. Wheater’s functional histology: a text and color atlas, 5th ed. Philadelphia, PA: Churchill Livingstone Elsevier Ltd, 2009:302–27.Search in Google Scholar

[27] Junqueira LC, Jose C, editors. Basic histology: text and atlas, 11th ed. New York, NY: McGraw-Hill, 2005:373–91.10.1007/b137678Search in Google Scholar

[28] Eroschenko VP. Urinary system. In: Eroschenko VP, editor. Di Fiore’s atlas of histology with functional correlations. Philadelphia, PA: Lippincott Williams & Wilkins, 2005:309–27.Search in Google Scholar

[29] Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med 2011;135:92–109.10.5858/2010-0478-RAR.1Search in Google Scholar PubMed

[30] Kuroda N, Tanaka A, Ohe C, Nagashima Y. Recent advances of immunohistochemistry for diagnosis of renal tumors. Pathol Int 2013;63:381–90.10.1111/pin.12080Search in Google Scholar PubMed

[31] Sulemanji M, Vakili K. Neonatal renal physiology. Semin Pediatr Surg 2013;22:195–8.10.1053/j.sempedsurg.2013.10.008Search in Google Scholar PubMed

[32] Schlöndorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1987;1:272–81.10.1096/fasebj.1.4.3308611Search in Google Scholar PubMed

[33] Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development 2008;135:609–20.10.1242/dev.001081Search in Google Scholar PubMed

[34] Pfeilschifter J. Regulatory functions of protein kinase c in glomerular mesangial cells. Klin Wochenschr 1990;68:1134–7.10.1007/BF01798064Search in Google Scholar PubMed

[35] D’Acunto CW, Gbelcova H, Festa M, Ruml T. The complex understanding of Annexin A1 phosphorylation. Cell Signal 2014;26:173–8.10.1016/j.cellsig.2013.09.020Search in Google Scholar PubMed

[36] Boudhraa Z, Viallard B, Bouchon C, D’Incan M, Degoul F. Annexin A1 localization and its relevance to cancer. Clin Sci 2016;130:205–20.10.1042/CS20150415Search in Google Scholar PubMed

[37] Ka SM, Tsai PY, Chao TK, Yang SM, Hung YJ, Chen JS, et al. Urine annexin A1 as an index for glomerular injury in patients. Dis Markers 2014:1–12.10.1155/2014/854163Search in Google Scholar PubMed PubMed Central

[38] Perretti M, Dalli J. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol 2009;158:936–46.10.1111/j.1476-5381.2009.00483.xSearch in Google Scholar PubMed PubMed Central

[39] Weyd H, Abeler-Dörner L, Linke B, Mahr A, Jahndel V, Pfrang S, et al. Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity. PLoS One 2013;8:e62449.10.1371/journal.pone.0062449Search in Google Scholar PubMed PubMed Central

[40] Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008;19:1634–42.10.1681/ASN.2007121336Search in Google Scholar PubMed

[41] Cortes-Hernandez J, Fossati-Jimack L, Carugati A, Potter PK, Walport MJ, Cook HT, et al. Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms. Clin Exp Immunol 2002;130:459–66.10.1046/j.1365-2249.2002.01998.xSearch in Google Scholar PubMed PubMed Central

[42] Schnenberger E, Ehrich JH, Haller H, Schiffer M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 2011;26:18–24.10.1093/ndt/gfq617Search in Google Scholar PubMed

[43] Miesen L, Steenbergen E, Smeets B. Parietal cells – new perspectives in glomerular disease. Cell Tissue Res 2017;369:237–44.10.1007/s00441-017-2600-5Search in Google Scholar PubMed PubMed Central

[44] Zimmermann U, Woenckhaus C, Teller S, Venz S, Langheinrich M, Protzel C, et al. Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. Histol Histopathol 2007;22:527–34.Search in Google Scholar

[45] Yamanoi M, Yamanoi K, Fujii C, Fukuda MN, Nakayama J. Annexin A1 expression is correlated with malignant potential of renal cell carcinoma. Int J Urol 2019;26:284–90.10.1111/iju.13869Search in Google Scholar PubMed

[46] Sheikh MH, Solito E. Annexin A1: uncovering the many talents of an old protein. Int J Mol Sci 2018;19:1–20.10.3390/ijms19041045Search in Google Scholar PubMed PubMed Central

[47] Gerosa C, Fanni D, Nemolato S, Di Felice E, Iacovidou N, Eyken PV, et al. Shift of galectin-3 expression in the human kidney during development. J Pediatr Neonat Individual Med 2013;2:1–6.Search in Google Scholar

[48] Thedieck C, Kuczyk M, Klingel K, Steiert I, Müller CA, Klein G. Expression of Ksp-cadherin during kidney development and in renal cell carcinoma. Br J Can 2005;92:2010–7.10.1038/sj.bjc.6602597Search in Google Scholar PubMed PubMed Central

Received: 2019-06-24
Accepted: 2019-09-10
Published Online: 2019-11-14

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 20.4.2024 from https://www.degruyter.com/document/doi/10.1515/jbcpp-2019-0179/html
Scroll to top button